Development and evaluation of novel polymeric nanoparticles of brimonidine tartrate

Current Drug Delivery

Volumn 7, Issue 3, 2010, Pages 244-251

  Singh, Kavita H ^a   Shinde, Ujwala A ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Brimonidine tartrate; Chitosan; Ionic gelation; Nanoparticles; Sodium alginate

Indexed keywords

ALGINIC ACID; BRIMONIDINE; NANOPARTICLE; POLYMER; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; FEMALE; GELATION; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; THERMOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR PRESSURE; KINETICS; MEDICINAL CHEMISTRY; NANOTECHNOLOGY; RABBIT; SOLUBILITY;

ADMINISTRATION, OPHTHALMIC; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ALGINATES; ANIMALS; BRIMONIDINE TARTRATE; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG STABILITY; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; INTRAOCULAR PRESSURE; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOTECHNOLOGY; PARTICLE SIZE; RABBITS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

EID: 77954661916     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720110791561008     Document Type: Article

References (21)

1. Yasmin, Sultana.; R, Jain.; M, Aqil.; Asgar, A. Review of ocular drug delivery: Curr. Drug Deliv., 2006, 3(2), 207-217.
2. nd ed., In: Mitra, A. K.; Ed., New York, Marcel Dekker, 2003, pp. 1-11.
3. Sanjeeb, K. Sahoo.; S. Krishnakumar.; Fahima, Dilnawaz. Nanotechnology in ocular drug delivery. Drug Discov. Today, 2008, 13(3-4), 144-151.
4. Mundada, A.S.; Nanoparticles: Application in Ophthalmic Drug Delivery System. Pharma Times, 2006, 38(3), 13-17.
5. Jae H.P.; Mingli Ye.; Park K. Biodegradable Polymers for Micro encapsulation of Drugs. Molecules, 2005, 10,146-161.
6. De T. K.; Bergey E. J.; Chung S. J.; Rodman D. J.; Bharali D. J.; Prasad P. N. Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea. J. Microencapsul., 2004, 21(8): 841-855.
7. Rajaonarivony M.; Vauthier C.; Couarraze G.; Puisieux F.; Couvreur P. Development of new drug carrier made from alginate. J. Pharm. Sci., 1993, 82(9), 912-917.
8. Khuller, G.K.; Zahoor, A.; Sharma, S. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob. Agents, 2005, 26, 298-303.
9. Papadimitriou, S.; Bikiaris, D.; Avgoustakis, K.; Karavas, E.; Georgarakis, M.; Chitosan naoparticles loaded with dorzolamide and pramipexole: Carbohydr. Polym., 2008, 73(1), 44-54.
10. R. Kirk, Wilhelmus.; Draize test. Survey Ophthalmol., 2001, 45(6), 493-515.
11. Calabrese, E.J. Principle of Animal extrapolation, Dermatotoxicity, Predictive models, Opthalmic irritancy predictability, Lewis Publisher, USA, 2002, p. 392.
12. Ballantyne, B. General and Applied Toxicology. Ballantyne, B.; Mars, T.; Turner, P., Eds. Grove's Dictionaries, USA, 1993, pp. 504-519.
13. nd ed.; Springer, USA, 2002, pp. 1295-1297.
14. Motwani, S.K.; Chopra, S.; Talegaonkar, S.; Kohli, K.; Ahmad, F. J.; Khar, R.K. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimization and in vitro characterization. Eur. J. Pharm. Biopharm., 2008, 68, 513-525.
15. Chuanyun, D.; Bochu, W.; Hongwei, Z. Microencapsulation peptide and protein drugs delivery system. Coll. Surf. B. Biointerf., 2005, 41(2-3), 117-120.
16. Wiesner, M. R.; Bottero, J. Environmental nanotechnology.; method for structural and chemical characterization of nanomaterials. McGraw Hill, USA, 2007, p. 144.
17. Zeta potential theory. Available at http://www.pssnicomp.com/zetatheory.htm. [Accessed Dec 2008].
18. Zeta Potential of Colloids in Water and Waste Water. American Society for Testing and Materials. ASTM Standard D 4187-82, 1985.
19. De T. K.; Bergey, E. J.; Chung, S. J.; Rodman, D. J.; Bharali, D. J. Prasad, P. N. Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea. J. Micro-encapsul., 2004, 21(8), 841-855.
20. Yaowalak, B.; Ampol, M.; Mueller, B. W.; Chitosan drug binding by ionic interaction. Eur. J. Pharm. Biopharm., 2006, 62, 267-274.
21. Banning, D.; William, D.P.; Gordon, J.I.; Chadwick, H.F.; Jarle, O.E.; Frederick, F.P.; MacKenzie, C.D.Q.; Hanne, K.A. Pourable Alginate compositions, US Patent 6,395,307, May 28, 2002.